After investigating for possible associations between SOX30 expression and clinico-pathologic features of the patients, we found that SOX30 expression was evidently correlated to histological type (n = 220, P = 0.008) and clinical stage (n = 220, P = 0.024) of NSCLC patients (Table 1). Here, SOX30 is linked to non-small cell lung carcinoma.